Literature DB >> 1850805

In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome.

P Ward1, K I Berns.   

Abstract

In an in vitro simian virus 40 (SV40) DNA replication assay, we have observed excision of a hybrid adeno-associated virus (AAV)/SV40 insert from a plasmid construct. The excision was dependent on the presence of the palindromic AAV terminal repeat and greatly enhanced by the addition of the SV40 T antigen to the reaction. Analysis of the excision product supports a model in which the palindromic terminal sequences of AAV form a cruciform structure (equivalent to a Holliday recombination intermediate), which is cleaved and resealed so that the excision products are linear duplex pBR322 and linear duplex AAV/SV40 insert. Both the excised linear duplex pBR322 and the excised linear duplex AAV/SV40 insert have each terminus covalently crosslinked by one copy of the palindromic region of the AAV terminal repeat region folded on itself. The excision process may be a model system for cellular homologous recombination. The process as observed was either concomitant with or subsequent to DNA replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850805     DOI: 10.1016/0022-2836(91)90267-a

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

Authors:  A Recchia; R J Parks; S Lamartina; C Toniatti; L Pieroni; F Palombo; G Ciliberto; F L Graham; R Cortese; N La Monica; S Colloca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system.

Authors:  P Ward; M Falkenberg; P Elias; M Weitzman; R M Linden
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 3.  The Gordon Wilson Lecture. From basic virology to human gene therapy.

Authors:  K I Berns
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

4.  Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2.

Authors:  J A Chiorini; B Zimmermann; L Yang; R H Smith; A Ahearn; F Herberg; R M Kotin
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

Review 5.  Large-scale recombinant adeno-associated virus production.

Authors:  Robert M Kotin
Journal:  Hum Mol Genet       Date:  2011-04-29       Impact factor: 6.150

6.  Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing.

Authors:  Philipp Kapranov; Lingxia Chen; Debra Dederich; Biao Dong; Jie He; Kathleen E Steinmann; Andrea R Moore; John F Thompson; Patrice M Milos; Weidong Xiao
Journal:  Hum Gene Ther       Date:  2011-10-04       Impact factor: 5.695

7.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element.

Authors:  Achille François; Mickaël Guilbaud; Rafi Awedikian; Gilliane Chadeuf; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication.

Authors:  Peter Ward; Per Elias; R Michael Linden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Homologous recombination of monkey alpha-satellite repeats in an in vitro simian virus 40 replication system: possible association of recombination with DNA replication.

Authors:  I Kawasaki; Y S Bae; T Eki; Y Kim; H Ikeda
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.